Lowes Cautions on Shifting Consumer Behavior Signaling Potential Headwinds Cathie Wood Issues Strong Bitcoin Prediction Market Watchers React Nvidias Earnings Reveal 200 Billion Opportunity in Edge Computing Despite China Concession SP Global Publishes Banking Industry Country Risk Assessment Key Factors and Implications US GDP Advance Estimate for Q4 and Full Year 2025 Released by BEA China Calls for APEC Cooperation as Commerce Minister Skips Opening Meeting Canada Goose GOOS Q1 2026 Earnings EPS Falls Short of Estimates Shares Edge Lower Keysight Technologies Q1 2026 Earnings Earnings Surge Past Estimates Stock Gains Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Highlights Progress in Clinical Pipeline VNT Q1 2026 Earnings EPS Misses Estimate by a Hair Stock Rises 246 BBLG Q1 2026 Earnings NarrowerthanExpected Loss as Company Advances Bone Graft Platform PureTech Health Q4 2024 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports Results Lifeward Ltd LFWD Surges Over 11 as Shares Test Key Resistance 17 Education Technology Group YQ Faces Continued Pressure Testing Key Support Levels Horizon Space Acquisition II Corp HSPT Holds Steady at 1001 Amid SPAC Market Calm Inno Holdings Inc INHD Edges Higher Approaching Key Resistance SmartFinancial Inc SMBK Edges Higher as Support Holds Resistance Looms at 4359 UK Police Chiefs Propose Blocking Unsafe Social Media for Under16s Raising Regulatory Risks for Tech Firms OI Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Slips Westrock Coffee WEST Slides 455 as Shares Test Key Support Levels Adamas Trust Notes ADAMI Edge Lower Amid Cautious Fixed Income Sentiment Liberty Media FWONA Edges Higher as Formula One Growth Narrative Gains Traction Allogene Therapeutics Edges Higher Testing Key Resistance at 21 SLM Corporation SLM Edges Lower as Traders Eye Support Levels Cross Country Healthcare CCRN Holds Steady Near Key Support as Trading Volume Remains Subdued TrustCo Bank TRST Edges Lower Amid Consolidation Near Key Support Levels ProQR Therapeutics PRQR Edges Higher as Shares Approach Key Resistance Levels